Live financial news intelligence

Track market-moving stories before they get noisy

Real-time pulse of financial headlines curated from 5 premium feeds.

Latest market signal Czech Filtered by asset MOH
Coverage 92,428 Raw stories ingested 7,968 rewritten in CS_CZ • 0 to rewrite (last 2 days).
Agents 7 waiting Pipeline agents
  • FMP Stock News Fetch every minute 58s ago
  • FMP Forex News Fetch every 5 min 2m ago
  • CoinGecko News Fetch every 5 min 2m ago
  • FIO Stock News Fetch every 10 min 1m ago
  • Patria Stock News Fetch every 10 min 1m ago
  • Editorial rewrite Rewrite every minute 58s ago
  • Asset sync Assets every 1 hour 11m ago

Latest coverage

Market News Feed

Scan headlines quickly, then expand any story for source context.

View
Language
Relevance
Clear
Details Date Content Source Relevance
2026-07-22 23:04 3d ago
2026-07-22 18:56 3d ago
Molina překonala odhad zisku, tržby lehce zaostaly
MOH Molina Healthcare
FMP Stock News 78
Original source text
Molina (MOH - Free Report) came out with quarterly earnings of $1.51 per share, beating the Zacks Consensus Estimate of $1.37 per share. This compares to earnings of $5.48 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of +10.22%. A quarter ago, it was expected that this provider of Medicaid-related services would post earnings of $1.57 per share when it actually produced earnings of $2.35, delivering a surprise of +49.68%.

Over the last four quarters, the company has surpassed consensus EPS estimates two times.

Molina, which belongs to the Zacks Medical - HMOs industry, posted revenues of $10.87 billion for the quarter ended June 2026, missing the Zacks Consensus Estimate by 0.08%. This compares to year-ago revenues of $11.43 billion. The company has topped consensus revenue estimates two times over the last four quarters.

The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call.

Molina shares have added about 30.5% since the beginning of the year versus the S&P 500's gain of 9.7%.

What's Next for Molina?While Molina has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock?

There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately.

Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions.

Ahead of this earnings release, the estimate revisions trend for Molina was mixed. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #3 (Hold) for the stock. So, the shares are expected to perform in line with the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

It will be interesting to see how estimates for the coming quarters and the current fiscal year change in the days ahead. The current consensus EPS estimate is $1.01 on $11.06 billion in revenues for the coming quarter and $5.23 on $44.41 billion in revenues for the current fiscal year.

Investors should be mindful of the fact that the outlook for the industry can have a material impact on the performance of the stock as well. In terms of the Zacks Industry Rank, Medical - HMOs is currently in the top 10% of the 250 plus Zacks industries. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

The Joint Corp. (JYNT - Free Report) , another stock in the same industry, has yet to report results for the quarter ended June 2026.

This company is expected to post quarterly earnings of $0.11 per share in its upcoming report, which represents a year-over-year change of +283.3%. The consensus EPS estimate for the quarter has remained unchanged over the last 30 days.

The Joint Corp.'s revenues are expected to be $14.7 million, up 10.7% from the year-ago quarter.
2026-07-21 15:48 4d ago
2026-07-21 10:16 5d ago
Analytici čekají prudký pokles zisku a tržeb společnosti Molina
MOH Molina Healthcare
FMP Stock News 78
Original source text
Analysts on Wall Street project that Molina (MOH - Free Report) will announce quarterly earnings of $1.37 per share in its forthcoming report, representing a decline of 75% year over year. Revenues are projected to reach $10.88 billion, declining 4.8% from the same quarter last year.

The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.

Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.

While investors typically rely on consensus earnings and revenue estimates to gauge how the business may have fared during the quarter, examining analysts' projections for some of the company's key metrics often helps gain a deeper insight.

In light of this perspective, let's dive into the average estimates of certain Molina metrics that are commonly tracked and forecasted by Wall Street analysts.

The consensus among analysts is that 'Revenue- Premium revenue- Marketplace' will reach $643.41 million. The estimate indicates a change of -46.4% from the prior-year quarter.

Based on the collective assessment of analysts, 'Revenue- Premium tax revenue' should arrive at $437.04 million. The estimate suggests a change of +1.4% year over year.

Analysts predict that the 'Revenue- Premium revenue- Medicaid' will reach $8.16 billion. The estimate indicates a year-over-year change of +1.6%.

According to the collective judgment of analysts, 'Revenue- Premium revenue- Medicare' should come in at $1.63 billion. The estimate indicates a change of +1.2% from the prior-year quarter.

The average prediction of analysts places 'MCR - Medicaid' at 92.9%. Compared to the present estimate, the company reported 91.3% in the same quarter last year.

The collective assessment of analysts points to an estimated 'MCR - Medicare' of 93.7%. Compared to the present estimate, the company reported 90.0% in the same quarter last year.

Analysts expect 'MCR - Marketplace' to come in at 84.9%. Compared to the current estimate, the company reported 85.4% in the same quarter of the previous year.

The consensus estimate for 'Ending Membership by Program - Total' stands at 5.00 million. The estimate is in contrast to the year-ago figure of 5.75 million.

It is projected by analysts that the 'Ending Membership by Program - Medicaid' will reach 4.48 million. Compared to the current estimate, the company reported 4.77 million in the same quarter of the previous year.

Analysts' assessment points toward 'Ending Membership by Program - Medicare' reaching 230.66 thousand. The estimate compares to the year-ago value of 267.00 thousand.

Analysts forecast 'Ending Membership by Program - Marketplaces' to reach 285.05 thousand. The estimate is in contrast to the year-ago figure of 690.00 thousand.

The combined assessment of analysts suggests that 'MCR - Total' will likely reach 92.5%. Compared to the present estimate, the company reported 90.4% in the same quarter last year.

View all Key Company Metrics for Molina here>>>

Molina shares have witnessed a change of +16.4% in the past month, in contrast to the Zacks S&P 500 composite's -0.6% move. With a Zacks Rank #3 (Hold), MOH is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .